Ftse Mib
34.683,22
0,55%
DAX
18.608,16
0,68%
S&P 500
5.243,39
-0,65%
NASDAQ
16.709,52
-0,15%
Bitcoin
68.970,85
1,80%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Quoin Pharmaceuticals Ltd (QNRX) Quoin Pharmaceuticals Ltd (QNRX) Notizie

Quoin Pharmaceuticals Ltd

QNRX
0,74
-0,0371 (-4,77%)
Ultimo aggiornamento: 18:17:34
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/5/202422:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/5/202414:30GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
08/5/202422:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/5/202422:10GLOBEQuoin Pharmaceuticals to Announce First Quarter 2024..
13/3/202421:05GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
13/3/202412:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
08/3/202422:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/3/202422:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/3/202422:01EDGAR2Form 8-K - Current report
07/3/202422:05GLOBEQuoin Pharmaceuticals Announces Fourth Quarter and 2023..
06/3/202423:07EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
06/3/202422:01EDGAR2Form 8-K - Current report
05/3/202414:00GLOBEQuoin Pharmaceuticals Announces Pricing of $6.5 Million..
04/3/202423:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/3/202414:00GLOBEQuoin Pharmaceuticals Announces FDA Clearance to Recruit..
27/2/202412:01EDGAR2Form DEF 14A - Other definitive proxy statements
15/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14/2/202402:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:50EDGAR2Form S-1/A - General form for registration of securities..
13/2/202422:30EDGAR2Form PRE 14A - Other preliminary proxy statements
12/2/202423:12EDGAR2Form S-1 - General form for registration of securities under..
08/2/202414:00GLOBEQuoin Pharmaceuticals Files U.S. and International Patent..
30/1/202422:05EDGAR2Form 8-K - Current report
18/12/202323:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/12/202323:29EDGAR2Form 8-K - Current report
13/12/202314:30GLOBEQuoin Pharmaceuticals Announces FDA Clearance of Clinical..
09/11/202323:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/11/202323:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:10EDGAR2Form 8-K - Current report
08/11/202323:46GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
07/11/202323:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/11/202322:17EDGAR2Form 8-K - Current report
03/11/202313:41GLOBEQuoin Pharmaceuticals Announces Third Quarter 2023 Financial..
01/11/202322:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/11/202321:59EDGAR2Form 8-K - Current report
30/10/202321:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202315:32GLOBEREPEAT -- Quoin Pharmaceuticals Announces Additional..
24/10/202314:28GLOBEQuoin Pharmaceuticals Announces Additional Positive Clinical..
19/10/202323:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/9/202322:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/9/202312:03EDGAR2Form DEF 14A - Other definitive proxy statements
01/9/202319:38EDGAR2Form PRE 14A - Other preliminary proxy statements
03/8/202322:51EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/8/202320:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202323:01EDGAR2Form 8-K - Current report
02/8/202322:45GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
Apertura: 0,7904 Min: 0,73 Max: 0,7904
Chiusura: 0,7771

La tua Cronologia

NASDAQ
QNRX
Quoin Pharmaceuticals
USOTC
LONKF
Lonking (PK)
BIT
F39623
Vontobel Financial Produ...
BIT
S30145
Societe Generale Effekten
BIT
P1TR91
BNP Paribas Issuance
BIT
F39584
Vontobel Financial Produ...
EU
M884S
M884S
LSE
AP62
Toy.mf.n.25
TSXV
CAW.P
USOTC
ADRAU
Adara Acquisition (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network